Drug-induced lupus erythematosus physical examination: Difference between revisions
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Drug-induced lupus erythematosus}} | {{Drug-induced lupus erythematosus}} | ||
{{CMG}}; {{AE}} {{CZ}} | |||
{{CMG}}; | |||
==Overview== | ==Overview== |
Latest revision as of 18:49, 22 June 2016
Drug-induced lupus erythematosus Microchapters |
Differentiating Drug-induced lupus erythematosus from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Drug-induced lupus erythematosus physical examination On the Web |
American Roentgen Ray Society Images of Drug-induced lupus erythematosus physical examination |
FDA on Drug-induced lupus erythematosus physical examination |
CDC on Drug-induced lupus erythematosus physical examination |
Drug-induced lupus erythematosus physical examination in the news |
Blogs on Drug-induced lupus erythematosus physical examination |
Directions to Hospitals Treating Drug-induced lupus erythematosus |
Risk calculators and risk factors for Drug-induced lupus erythematosus physical examination |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Cafer Zorkun, M.D., Ph.D. [2]
Overview
Physical Examination
Vitals
Skin
- Butterfly shaped rash on the face